Product Information

LOTEPREDNOL ETABONATE 0.2% DRP is a generic product labeled by Bausch & Lomb Americas Inc., priced at $26.1776 per ML under NDC 82260036105. Its NADAC has been published 131 times since May 22, 2024.

FDA first approved this application on Mar 9, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LOTEPREDNOL ETABONATE 0.2% DRP

loteprednol etabonate
$26.1776per ML

Strength

2 mg/mL

NDC

82260036105

Classification

Generic

Dosage Form

SUSPENSION/ DROPS

Route

OPHTHALMIC

Effective Date

11/18/2026

Active Ingredients

LOTEPREDNOL ETABONATE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA020803

FDA Approved

3/9/1998

TE Code

AB

On Market Since

2/9/2024

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for LOTEPREDNOL ETABONATE 0.2% DRP has been published 131 times since May 22, 2024, and over the history we have for it it has declined 8.6%. The table below summarizes its recorded NADAC range and movement.

Current price$26.1776 per ML
All-time high$40.9627 (Nov 13, 2024)
All-time low$26.0966 (Jul 17, 2024)
52-week high$35.8511
52-week low$26.1776
Median price$34.8618
Average price$33.8092
Largest weekly change+21.3% (Aug 21, 2024)
Weeks tracked131
Tracking sinceMay 22, 2024

Price History

1W

-10.3%

1M

-14.8%

3M

-19.0%

6M

-14.1%

1Y

-26.1%

3Y

N/A

5Y

N/A

All

-8.6%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LOTEPREDNOL ETABONATE 0.2% DRP?

The current National Average Drug Acquisition Cost (NADAC) for LOTEPREDNOL ETABONATE 0.2% DRP, manufactured by Bausch & Lomb Americas Inc., is $26.1776 per ML (NDC 82260036105), effective Nov 18, 2026.

How has the price of LOTEPREDNOL ETABONATE 0.2% DRP changed over time?

Over the history we have for it, the NADAC for LOTEPREDNOL ETABONATE 0.2% DRP has declined 8.6%. It has been tracked across 131 weekly CMS publications since May 22, 2024.

What are the highest and lowest recorded NADAC prices for LOTEPREDNOL ETABONATE 0.2% DRP?

Since May 22, 2024, the NADAC for LOTEPREDNOL ETABONATE 0.2% DRP has ranged from a low of $26.0966 (Jul 17, 2024) to a high of $40.9627 (Nov 13, 2024), with a median of $34.8618 per ML.

Are there cheaper alternatives to LOTEPREDNOL ETABONATE 0.2% DRP?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LOTEPREDNOL ETABONATE 0.2% DRP in a comparable dosage form, but none are currently priced below it.

Who manufactures LOTEPREDNOL ETABONATE 0.2% DRP?

LOTEPREDNOL ETABONATE 0.2% DRP (NDC 82260036105) is labeled by Bausch & Lomb Americas Inc., and CMS classifies it as a generic product.